Advanced search
Publication Cover
Journal of Chemotherapy Volume 35, 2023 - Issue 5
Submit an article Journal homepage
212
Views
1
CrossRef citations to date
0
Altmetric
Case Report

Dalbavancin as chronic antibiotic suppression therapy for left ventricular assist device driveline infection due to methicillin-resistant Staphylococcus aureus: a case report

Carlo Pallottoa Infectious Diseases Clinic, Santa Maria della Misericordia Hospital, Department of Medicine and Surgery, University of Perugia, Perugia, ItalyCorrespondence[email protected] [email protected]
ORCID Iconhttps://orcid.org/0000-0002-0355-2885View further author information
ORCID Icon,
Sara Tordia Infectious Diseases Clinic, Santa Maria della Misericordia Hospital, Department of Medicine and Surgery, University of Perugia, Perugia, ItalyView further author information
,
Romina Pantanellab Department of Cardiac Surgery, Santa Maria della Misericordia Hospital, Perugia, ItalyView further author information
,
Daniele Rosignolia Infectious Diseases Clinic, Santa Maria della Misericordia Hospital, Department of Medicine and Surgery, University of Perugia, Perugia, ItalyView further author information
&
Daniela Franciscia Infectious Diseases Clinic, Santa Maria della Misericordia Hospital, Department of Medicine and Surgery, University of Perugia, Perugia, ItalyView further author information
Pages 465-469 | Received 11 Jun 2022, Accepted 11 Oct 2022, Published online: 25 Oct 2022

References

  • Zinoviev R, Lippincott CK, Keller SC, et al. In full flow: left ventricular assist device infections in the modern era. Open Forum Infect Dis. 2020;7(5):ofaa124.
  • O’Horo JC, Abu Saleh OM, Stulak JM, et al. Left ventricular assist device infections: a systematic review. Asaio J. 2018;64(3):287–294.
  • Radcliffe C, Doilicho N, Niu YS, et al. Efficacy and safety of chronic antimicrobial suppression therapy for left ventricular assist device driveline infections: a single-center descriptive experience. Transpl Infect Dis. 2020;22(5):e13379.
  • Siméon S, Flécher E, Revest M, et al. Left ventricular assist device-related infections: a multicentric study. Clin Microbiol Infect. 2017;23(10):748–751.
  • Gatti M, Andreoni M, Pea F, et al. Real-world use of dalbavancin in the era of empowerment of outpatient antimicrobial treatment: a careful appraisal beyond approved indications focusing on unmet clinical needs. Drug Des Devel Ther. 2021;15:3349–3378.
  • Hieda M, Sata M, Nakatani T. The importance of the management of infectious complications for patients with left ventricular assist device. Healthcare (Basel). 2015;3(3):750–756.
  • Letsou GV, Anand J, Ogburn E, et al. Low incidence of pump-related infections in jarvik 2000 ventricular assist device recipients with a subcostal driveline exit-site. Tex Heart Inst J. 2019;46(3):179–182.
  • Ten Hove D, Treglia G, Slart RHJA, et al. The value of 18F-FDG PET/CT for the diagnosis of device-related infections in patients with a left ventricular assist device: a systematic review and Meta-analysis. Eur J Nucl Med Mol Imaging. 2021;48(1):241–253.
  • Dejust S, Guedec-Ghelfi R, Blanc-Autrant E, et al. Infection of ventricular assist device detected and monitored by 18F-FDG PET/CT. Clin Nucl Med. 2017;42(9):695–696.
  • Kusne S, Mooney M, Danziger-Isakov L, et al. An ISHLT consensus document for prevention and management strategies for mechanical circulatory support infection. J Heart Lung Transplant. 2017;36(10):1137–1153.
  • Hamad Y, Blanco-Guzman MO, Olsen MA, et al. The role of chronic suppressive antibiotics therapy in superficial drive line infection relapse of left ventricular assist devices: a retrospective cohort from a tertiary care center. Transpl Infect Dis. 2021;23(4):e13686.
  • Howard-Anderson J, Pouch SM, Sexton ME, et al. Left ventricular assist device infections and the potential role for dalbavancin: a case report. Open Forum Infect Dis. 2019;6(9):ofz235.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.